INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,470,204 | -22.5% | 46,496 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $1,896,107 | +15.5% | 46,496 | +5.6% | 0.01% | +16.7% |
| Q1 2023 | $1,641,035 | +6.8% | 44,031 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,536,242 | -31.5% | 44,031 | +9.8% | 0.01% | -36.8% |
| Q3 2022 | $2,244,052 | +10.6% | 40,101 | +2.3% | 0.02% | +11.8% |
| Q2 2022 | $2,028,164 | -25.3% | 39,184 | +4.9% | 0.02% | -5.6% |
| Q1 2022 | $2,715,097 | -4.9% | 37,362 | +54.7% | 0.02% | -25.0% |
| Q4 2021 | $2,855,851 | -11.9% | 24,153 | 0.0% | 0.02% | -20.0% |
| Q3 2021 | $3,240,125 | -12.2% | 24,153 | +6.0% | 0.03% | -14.3% |
| Q2 2021 | $3,688,957 | +130.5% | 22,784 | +14.2% | 0.04% | +133.3% |
| Q1 2021 | $1,600,525 | +47.5% | 19,943 | 0.0% | 0.02% | +36.4% |
| Q4 2020 | $1,084,899 | +173.6% | 19,943 | 0.0% | 0.01% | +175.0% |
| Q3 2020 | $396,467 | -5.4% | 19,943 | 0.0% | 0.00% | -20.0% |
| Q2 2020 | $419,202 | +117.8% | 19,943 | +26.7% | 0.01% | +66.7% |
| Q1 2020 | $192,512 | -16.6% | 15,741 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $230,920 | +9.9% | 15,741 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $210,142 | -18.4% | 15,741 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $257,680 | -4.2% | 15,741 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $268,856 | +25.1% | 15,741 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $214,865 | -52.3% | 15,741 | 0.0% | 0.00% | -40.0% |
| Q3 2018 | $450,507 | +4.5% | 15,741 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $431,000 | +169.4% | 15,741 | +107.2% | 0.01% | +150.0% |
| Q1 2018 | $160,000 | +9.6% | 7,597 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $146,000 | – | 7,597 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |